HALOZYME THERAPEUTICS, INC. (HALO) /
The profitability of HALOZYME THERAPEUTICS, INC. over the past 10 years
Chart HALOZYME THERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →HALOZYME THERAPEUTICS, INC. reported net income of $316.89M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $1.17B and operating income of $469.01M. It reported a profit in 7 of the 10 years shown, and a loss in fiscal 2016, 2018 and 2019. Its highest net income in these years was $444.09M, in fiscal 2024.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.17B* | $469.01M | $316.89M |
| 2024ended Dec 31, 2024 | $855.91M* | $551.48M | $444.09M |
| 2023ended Dec 31, 2023 | $636.89M* | $337.57M | $281.59M |
| 2022ended Dec 31, 2022 | $520.81M* | $267.53M | $202.13M |
| 2021ended Dec 31, 2021 | $361.9M* | $275.9M | $402.71M |
| 2020ended Dec 31, 2020 | $224.23M* | $144.25M | $129.09M |
| 2019ended Dec 31, 2019 | $150.45M* | -$67.61M | -$72.24M |
| 2018ended Dec 31, 2018 | $141.73M* | -$69.33M | -$80.33M |
| 2017ended Dec 31, 2017 | $285.46M* | $81M | $62.97M |
| 2016ended Dec 31, 2016 | $113.48M* | -$83.21M | -$103.02M |
Fiscal years as HALOZYME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on HALOZYME THERAPEUTICS, INC.
- The revenue of HALOZYME THERAPEUTICS, INC.
- The cash flow of HALOZYME THERAPEUTICS, INC.
- The debt of HALOZYME THERAPEUTICS, INC.
- All of HALOZYME THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- ALLEAllegion plc
- PNFPPINNACLE FINANCIAL PARTNERS, INC.
- JHXJAMES HARDIE INDUSTRIES plc
- SUISUN COMMUNITIES, INC
- BZKANZHUN LIMITED
Not investment advice. This page shows what HALOZYME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.